$2.40
3.45% yesterday
Nasdaq, Oct 15, 10:00 pm CET
ISIN
US19516Q2084
Symbol
CLGN

Collplant Holdings ADR Stock price

$2.40
-0.23 8.75% 1M
-0.06 2.24% 6M
-1.20 33.33% YTD
-2.06 46.19% 1Y
-4.81 66.71% 3Y
-4.82 66.76% 5Y
-25.46 91.38% 10Y
-16.07 87.00% 20Y
Nasdaq, Closing price Wed, Oct 15 2025
+0.08 3.45%
ISIN
US19516Q2084
Symbol
CLGN
Industry

Key metrics

Basic
Market capitalization
$30.5m
Enterprise Value
$19.1m
Net debt
positive
Cash
$11.4m
Shares outstanding
12.7m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
12.7 | 3.5
EV/Sales
8.0 | 2.2
EV/FCF
negative
P/B
2.4
Financial Health
Equity Ratio
72.0%
Return on Equity
-123.4%
ROCE
-90.8%
ROIC
-
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$2.4m | $8.8m
EBITDA
$-12.4m | -
EBIT
$-13.3m | $-6.9m
Net Income
$-13.0m | $-4.1m
Free Cash Flow
$-10.7m
Growth (TTM | estimate)
Revenue
247.8% | 1,600.8%
EBITDA
28.5% | -
EBIT
27.5% | 59.2%
Net Income
25.6% | 75.4%
Free Cash Flow
-205.7%
Margin (TTM | estimate)
Gross
61.8%
EBITDA
-515.1% | -
EBIT
-555.5%
Net
-541.3% | -46.2%
Free Cash Flow
-446.7%
More
EPS
$-1.1
FCF per Share
$-0.8
Short interest
0.5%
Employees
57
Rev per Employee
$10.0k
Show more

Is Collplant Holdings ADR a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,003 stocks worldwide.

Collplant Holdings ADR Stock Analysis

Unlock Scores for Free

Analyst Opinions

8 Analysts have issued a Collplant Holdings ADR forecast:

7x Buy
88%
1x Hold
13%

Analyst Opinions

8 Analysts have issued a Collplant Holdings ADR forecast:

Buy
88%
Hold
13%

Financial data from Collplant Holdings ADR

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
2.40 2.40
248% 248%
100%
- Direct Costs 0.92 0.92
57% 57%
38%
1.48 1.48
203% 203%
62%
- Selling and Administrative Expenses 5.30 5.30
12% 12%
221%
- Research and Development Expense 9.53 9.53
13% 13%
397%
-12 -12
29% 29%
-515%
- Depreciation and Amortization 0.97 0.97
11% 11%
40%
EBIT (Operating Income) EBIT -13 -13
28% 28%
-556%
Net Profit -13 -13
26% 26%
-542%

In millions USD.

Don't miss a Thing! We will send you all news about Collplant Holdings ADR directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Collplant Holdings ADR Stock News

Neutral
PRNewsWire
16 days ago
CollPlant is now moving towards clinical trials and scaling and optimizing its manufacturing to ensure readiness for the upcoming clinical trials REHOVOT, Israel , Sept. 30, 2025 /PRNewswire/ -- CollPlant Biotechnologies (NASDAQ: CLGN), a regenerative and aesthetic medicine company developing disruptive technologies and products based on its proprietary non-animal recombinant human collagen (rh...
Neutral
PRNewsWire
about one month ago
REHOVOT, Israel , Sept. 15, 2025 /PRNewswire/ -- CollPlant Biotechnologies (NASDAQ: CLGN), or 'CollPlant', a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived collagen for tissue regeneration and medical aesthetics, today announced the expansion of its European distribution network for Vergenix™ STR through the signing o...
Neutral
PRNewsWire
about one month ago
REHOVOT, Israel , Sept. 2, 2025 /PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetic medicine company developing disruptive technologies and products based on its non-animal-derived recombinant human collagen (rhCollagen), today announced its participation in the annual meeting of The International Society of Biofabrication: the International Conference on Biof...
More Collplant Holdings ADR News

Company Profile

CollPlant Biotechnologies Ltd. is a regenerative medicine company, which engages in the research, development, manufacture, and marketing of medical products for tissue repair such as bioprinting of tissues and organs, and medical aesthetics. The company's products include VergenixSTR, VergenixFG, and CollPlant Surgical Matrix. The company was founded by Oded Shoseyov in June 2004 and is headquartered in Rehovot, Israel.

Head office Israel
CEO Mr. Tal
Employees 57
Founded 2004
Website www.collplant.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today